Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALZN

Alzamend Neuro Inc

Jun 11 • 04:00PM ET

1.14

-0.01 -1.29 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.38	Insider Own	16.05%	Shs Outstand	3.80M	Perf Week	0.44%
Market Cap	4.36M	Forward P/E	-	EPS next Y	-2.60	Insider Trans	20.36%	Shs Float	3.19M	Perf Month	12.25%
Enterprise Value	1.65M	PEG	-	EPS next Q	-0.67	Inst Own	3.04%	Short Float	4.67%	Perf Quarter	-45.22%
Income	-7.63M	P/S	-	EPS this Y	75.82%	Inst Trans	-1.12%	Short Ratio	1.16	Perf Half Y	-47.24%
Sales	0.00M	P/B	1.99	EPS next Y	-0.78%	ROA	-171.39%	Short Interest	0.15M	Perf YTD	-37.09%
Book/sh	0.57	P/C	1.61	EPS next 5Y	-	ROE	-249.97%	52W High	3.60 -68.19%	Perf Year	-65.72%
Cash/sh	0.71	P/FCF	-	EPS past 3/5Y	60.75% 30.49%	ROIC	-322.36%	52W Low	0.84 36.31%	Perf 3Y	-99.87%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.41% 6.85%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	84.12%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.99	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.98	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.99	EPS Q/Q	65.91%	SMA20	1.57%	Beta	0.14	Target Price	25.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	6.51%	Rel Volume	0.18	Prev Close	1.16
Employees	7	LT Debt/Eq	0.00	Earnings	Mar 19	SMA200	-39.85%	Avg Volume	128.72K	Price	1.14
IPO	Jun 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-9.43% -	Trades		Volume	33,328	Change	-1.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)